Stifel analyst Craig Jones raised the firm’s price target on Oak Street Health (OSH) to $39 from $35 and keeps a Buy rating on the shares after The Wall Street Journal reported that CVS Health (CVS) is nearing an agreement to acquire the company for about $10.5B, or $39 per share. The firm, which thinks such an acquisition "would make a lot of sense for both companies," noted that CVS reports earnings Wednesday morning and said this "seems like a logical time to announce this acquisition."
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on OSH:
- CVS Finally Confirms OSH Deal; Beats Q4 Expectations
- CVS Health to Acquire Oak Street Health
- Report: CVS Close to Snapping up Oak Street for $10.5B; OSH Soars
- Oak Street ‘particularly attractive’ in current environment, says Piper Sandler
- CVS Health near deal to acquire Oak Street Health for $10.5B, WSJ says